Table 1 /Baseline demographics in patients undergoing elective coronary procedures

Number of subject

114

16

13

3

CKD stage III: CKD stage IV

90:24

10:6

9:4

1:2

Age (yr)

70 ± 10

72 ± 7

73 ± 5

70 ± 9

0.67

Men: women

88:26

12:4

10:3

2:1

0.17

SBP (mmHg)

129 ± 17

125 ± 13

125 ± 14

124 ± 14

0.65

DBP(mmHg)

71 ± 10

69 ± 12

70 ± 12

67 ± 8

0.74

Heart rate

75 ± 10

74 ± 12

76 ± 11

72 ± 8

0.48

Height (cm)

162 ± 9

161 ± 9

160 ± 7

162 ± 8

0.85

Weight (kg)

60 ± 13

56 ± 7

58 ± 5

54 ± 8

0.16

Body mass index (kg/m2)

24 ± 4

23 ± 3

23 ± 3

21 ± 4

0.14

Diabetes mellitus (%)

42

44

46

33

0.25

Hypertension (%)

80

75

77

67

0.19

Hypercholesterolemia (%)

50

44

38

67

0.16

Myocardial infarction (%)

18

25

23

33

0.37

LVEF < 40% (%)

20

19

15

33

0.59

CCS > II (%)

96

94

92

100

0.49

NYHA > II (%)

44

44

38

67

0.6

Angiogram/PCI (%)

66

75

85

67

0.58

Number of vessel disease > 1 (%)

61

63

50

67

0.62

ACEI (%)

30

31

31

33

0.42

ATRA (%)

40

31

31

33

0.48

Beta blocker (%)

54

44

38

67

0.56

CCB (%)

28

31

31

33

0.26

Diuretic (%)

26

31

31

33

0.64

Aspirin (%)

72

63

62

67

0.51

Statin (%)

48

44

38

67

0.17

Nitrate (%)

38

38

31

67

0.14

Contrast volume (ml)

126 ± 65

129 ± 90

126 ± 80

124 ± 92

0.43

IV volume (ml)

1483 ± 453

1591 ± 260

1598 ± 246

1562 ± 128

0.48

Total risk score

8 ± 3

8 ± 3

8 ± 3

9 ± 1

0.24